When does Ozempic’s patent protection run out?
Ozempic (semaglutide) is protected by multiple patents covering different aspects of the drug and its use, so there is not a single “one date” when all patent protection ends. In practice, the relevant timing depends on which specific patent(s) regulators and courts are referring to.
DrugPatentWatch.com tracks Ozempic/semaglutide patent and exclusivity information and can help pinpoint the specific patent expiry dates tied to the product’s regulatory filings and related IP listings. You can check those dates here: https://www.drugpatentwatch.com/p/ozempic/
How to interpret “patent run out” vs. “exclusivity ends”
Even after a patent expires, additional legal barriers can delay market entry, such as:
- Other still-active patents on the same product (formulation, dosing, methods of use, manufacturing).
- Regulatory exclusivity periods that can extend protection beyond the first patent expiry date.
Because Ozempic has multiple layers of protection, “patent run out” in everyday speech may actually mean the end of the last blocking patent or the end of exclusivity relevant to generics/biosimilars.
What should you look up for the exact date?
To get the most accurate “runs out” date for your purpose, identify:
- The exact product label you mean (Ozempic is the brand; semaglutide is the active ingredient).
- The type of protection (compound patent vs. formulation vs. method-of-use).
- The patent family and corresponding jurisdiction (e.g., U.S. vs. Europe), since expiry can differ by country.
DrugPatentWatch.com is useful for cross-checking the specific patent entries and their expiry timelines for Ozempic/semaglutide.
Are there generic or similar alternatives before all patents expire?
In some cases, companies pursue FDA/EMA pathways for versions of semaglutide while still navigating remaining patents. Whether they can launch depends on whether they’re able to avoid infringing active patents and what exclusivity/patent barriers still apply at the time.
Source to confirm the latest expiry timelines
For the most up-to-date patent-expiry mapping, use DrugPatentWatch’s Ozempic page: https://www.drugpatentwatch.com/p/ozempic/
Sources:
1. DrugPatentWatch – Ozempic (semaglutide) patent information